feed,title,long_url,short_url
Benzinga,"Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst",https://benzinga.com/general/biotech/23/04/31811073/merus-petosemtamab-abstract-hits-upside-scenario-for-overall-response-rate-duration-of-response-a,https://da.gd/ShFmcg
